296 related articles for article (PubMed ID: 32062751)
21. FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity.
Qureshi R; Yildirim O; Gasser A; Basmadjian C; Zhao Q; Wilmet JP; Désaubry L; Nebigil CG
PLoS One; 2015; 10(11):e0141826. PubMed ID: 26536361
[TBL] [Abstract][Full Text] [Related]
22. Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects.
Bentayeb H; Aitamer M; Petit B; Dubanet L; Elderwish S; Désaubry L; de Gramont A; Raymond E; Olivrie A; Abraham J; Jauberteau MO; Troutaud D
J Exp Clin Cancer Res; 2019 Nov; 38(1):450. PubMed ID: 31684984
[TBL] [Abstract][Full Text] [Related]
23. Prohibitins and the functional compartmentalization of mitochondrial membranes.
Osman C; Merkwirth C; Langer T
J Cell Sci; 2009 Nov; 122(Pt 21):3823-30. PubMed ID: 19889967
[TBL] [Abstract][Full Text] [Related]
24. Prohibitins are required for cancer cell proliferation and adhesion.
Sievers C; Billig G; Gottschalk K; Rudel T
PLoS One; 2010 Sep; 5(9):e12735. PubMed ID: 20856874
[TBL] [Abstract][Full Text] [Related]
25. Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes.
Lucas CR; Cordero-Nieves HM; Erbe RS; McAlees JW; Bhatia S; Hodes RJ; Campbell KS; Sanders VM
J Immunol; 2013 Jan; 190(2):723-36. PubMed ID: 23241883
[TBL] [Abstract][Full Text] [Related]
26. Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies.
Najem A; Krayem M; Sabbah S; Pesetti M; Journe F; Awada A; Désaubry L; Ghanem GE
Cells; 2023 Jul; 12(14):. PubMed ID: 37508519
[TBL] [Abstract][Full Text] [Related]
27. Prohibitins: mitochondrial partners in development and stress response.
Van Aken O; Whelan J; Van Breusegem F
Trends Plant Sci; 2010 May; 15(5):275-82. PubMed ID: 20226718
[TBL] [Abstract][Full Text] [Related]
28. Functional studies of
Chellappan S; Roy S; Nagmoti JM; Tabassum W; Hoti SL; Bhattacharyya MK; Nina PB
Indian J Med Microbiol; 2020; 38(2):213-215. PubMed ID: 32883936
[TBL] [Abstract][Full Text] [Related]
29. PHB in Cardiovascular and Other Diseases: Present Knowledge and Implications.
Chowdhury D; Kumar D; Sarma P; Tangutur AD; Bhadra MP
Curr Drug Targets; 2017 Nov; 18(16):1836-1851. PubMed ID: 27557820
[TBL] [Abstract][Full Text] [Related]
30. Effect of all-trans retinoic acid treatment on prohibitin and renin-angiotensin-aldosterone system expression in hypoxia-induced renal tubular epithelial cell injury.
Zhou TB; Ou C; Rong L; Drummen GP
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):243-9. PubMed ID: 25031298
[TBL] [Abstract][Full Text] [Related]
31. Cholix toxin, an eukaryotic elongation factor 2 ADP-ribosyltransferase, interacts with Prohibitins and induces apoptosis with mitochondrial dysfunction in human hepatocytes.
Yahiro K; Ogura K; Terasaki Y; Satoh M; Miyagi S; Terasaki M; Yamasaki E; Moss J
Cell Microbiol; 2019 Aug; 21(8):e13033. PubMed ID: 31009148
[TBL] [Abstract][Full Text] [Related]
32. Signaling pathways of prohibitin and its role in diseases.
Zhou TB; Qin YH
J Recept Signal Transduct Res; 2013; 33(1):28-36. PubMed ID: 23327602
[TBL] [Abstract][Full Text] [Related]
33. Characterization and functionality of two members of the SPFH protein superfamily, prohibitin 1 and 2 in Leishmania major.
Cruz-Bustos T; Ibarrola-Vannucci AK; Díaz-Lozano I; Ramírez JL; Osuna A
Parasit Vectors; 2018 Dec; 11(1):622. PubMed ID: 30514373
[TBL] [Abstract][Full Text] [Related]
34. Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma.
Luan Z; He Y; Alattar M; Chen Z; He F
Mol Cancer; 2014 Feb; 13():38. PubMed ID: 24568222
[TBL] [Abstract][Full Text] [Related]
35. The emerging roles of prohibitins in folliculogenesis.
Chowdhury I; Garcia-Barrio M; Harp D; Thomas K; Matthews R; Thompson WE
Front Biosci (Elite Ed); 2012 Jan; 4(2):690-9. PubMed ID: 22201905
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib.
Doudican NA; Orlow SJ
Oncogene; 2017 Jan; 36(3):423-428. PubMed ID: 27321184
[TBL] [Abstract][Full Text] [Related]
37. Prohibitins function as endogenous ligands for Siglec-9 and negatively regulate TCR signaling upon ligation.
Yurugi H; Tanida S; Akita K; Ishida A; Toda M; Nakada H
Biochem Biophys Res Commun; 2013 May; 434(2):376-81. PubMed ID: 23567969
[TBL] [Abstract][Full Text] [Related]
38. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway.
Liu S; Wang W; Brown LE; Qiu C; Lajkiewicz N; Zhao T; Zhou J; Porco JA; Wang TT
EBioMedicine; 2015 Nov; 2(11):1600-6. PubMed ID: 26870784
[TBL] [Abstract][Full Text] [Related]
39. Prohibitin( PHB) roles in granulosa cell physiology.
Chowdhury I; Thomas K; Thompson WE
Cell Tissue Res; 2016 Jan; 363(1):19-29. PubMed ID: 26496733
[TBL] [Abstract][Full Text] [Related]
40. Prohibitin S-Nitrosylation Is Required for the Neuroprotective Effect of Nitric Oxide in Neuronal Cultures.
Qu Y; Konrad C; Anderson C; Qian L; Yin T; Manfredi G; Iadecola C; Zhou P
J Neurosci; 2020 Apr; 40(16):3142-3151. PubMed ID: 32152200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
